Loading…
ZR2 Bioenergy (BSE 506640)₹127.50−0.39%Commodity Chemicals
ZR2 Bioenergy is compared with the 10 closest in size in Commodity Chemicals (80 companies in the industry). It has a P/E of 74.6 against a peer median of 19.4, and ROCE of 0.7% against a peer median of 6.9%. By market cap it is #4 of 11 in this set.
As of · Peer set: 10 closest in size in Commodity Chemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanti Inorganics | 317 | 20.9 | 23.0 | 27.6 | 0.64 | 0.0 | 71 | 10 | — | — | vs BSE 506640 |
| National Peroxide | 299 | 27.4 | 4.0 | 3.3 | 0.04 | 0.0 | 289 | 11 | 16.2 | — | vs BSE 506640 |
| Shree Hari Chemicals Export | 233 | 17.9 | 11.1 | 10.8 | 0.74 | 0.0 | 183 | 4 | 125.6 | — | vs BSE 506640 |
| ZR2 Bioenergy | 203 | 74.6 | 0.7 | 0.7 | 0.00 | 0.1 | 0 | 1 | — | −30.0 | — |
| ARCL Organics | 199 | 19.4 | 16.9 | 6.8 | 0.87 | 0.0 | 272 | 5 | −0.7 | 128.4 | vs BSE 506640 |
| ARCL Organics | 171 | 16.7 | 16.9 | 7.0 | 0.86 | 0.0 | 272 | 5 | −0.6 | 128.9 | vs BSE 506640 |
| Kanchi Karpooram | 164 | 21.4 | 4.0 | 2.4 | 0.00 | 0.3 | 149 | 5 | 16.4 | 112.7 | vs BSE 506640 |
| Archit Organosys | 141 | 17.5 | 12.9 | 11.0 | 0.33 | 0.7 | 141 | 8 | −15.4 | 0.0 | vs BSE 506640 |
| Kesar Petroproducts | 132 | 11.5 | 6.9 | 6.6 | 0.48 | 0.0 | 187 | 10 | 13.5 | −356.3 | vs BSE 506640 |
| Genus Prime Infra | 131 | 22.6 | 3.8 | 3.5 | 0.19 | 0.0 | 4 | 4 | 101.6 | — | vs BSE 506640 |
| AG Ventures | 125 | 3.2 | 2.0 | 1.9 | 0.08 | 0.0 | 108 | 8 | 193.2 | 1,612.1 | vs BSE 506640 |
| Peer median | 171 | 19.4 | 6.9 | 6.6 | 0.33 | 0.0 | 149 | 5 | 16.2 | 112.7 |
Listed companies closest to ZR2 Bioenergy in Commodity Chemicals include Shanti Inorganics, National Peroxide, Shree Hari Chemicals Export, ARCL Organics, ARCL Organics, Kanchi Karpooram, Archit Organosys, Kesar Petroproducts.
Shanti Inorganics, with a market cap of ₹317 Cr.
ZR2 Bioenergy trades at a P/E of 74.6; the median of its peer set is 19.4. A P/E above or below the median is a description, not a judgement on value.
ZR2 Bioenergy's return on capital employed is 0.7%, below the peer median of 6.9%.